In this model, the authors further demonstrated that, in vaccinated mice, the combination of anti-CD40 mAb and immune check point blockade using the anti-CTL-A4 mAb was able to delay tumor growth, resulting in complete regression and long-term survival of tumor-bearing mice. The gene discussed is CD40; the disease is neoplasm.